KHN’s ‘What the Health?’: We May Be Done With Covid, But Covid’s Not Done With Us
The White House makes a move as a new wave of covid threatens. President Joe Biden brings in Dr. Ashish Jha to take over the executive branch effort. Meanwhile, it remains unclear if and when Congress can come up with the funds to continue much of the federal anti-covid effort. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Sandhya Raman of CQ Roll Call, and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more.
It Was Already Hard to Find Evusheld, a Covid Prevention Therapy. Now It’s Even Harder.
At least 7 million immunocompromised people could benefit from the monoclonal antibody injections designed to prevent covid-19. The government says it has enough doses for a fraction of those in need ― and it doesn’t have the money to buy more.
Covid’s ‘Silver Lining’: Research Breakthroughs for Chronic Disease, Cancer, and the Common Flu
Billions of dollars invested in mRNA vaccines and covid research could yield health care dividends for decades to come.
Readers and Tweeters Remain Vigilant on Masking and Billing
KHN gives readers a chance to comment on a recent batch of stories.
Listen: What We’ve Learned After Two Years of the Pandemic
KHN Editor-in-Chief Dr. Elisabeth Rosenthal joins the CNN podcast “Reliable Sources” and reflects on the societal trauma that covid-19 has wrought.
Pandemic Medical Innovations Leave Behind People With Disabilities
As the country enters Year 3 of the pandemic emergency, people with disabilities across the U.S. are still finding it difficult to use innovations in telemedicine, teleworking, and testing.
KHN’s ‘What the Health?’: Congress Shelves Covid Funding for Now
The Biden administration’s request for billions more in funding to fight covid-19 hit a snag on Capitol Hill this week, as Democrats objected to Republican demands that money allocated to states but not yet spent be reclaimed. Meanwhile, the big annual spending bill about to cross the finish line addresses other health policy changes, such as giving the FDA authority to regulate “synthetic” nicotine. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Cohrs of Stat, and Jessie Hellmann of Modern Healthcare join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Two Years In, Covid Leaves Montana Public Health Officials Feeling ‘Watched’
Montanans engage in plenty of spirited political disagreements. But debates about covid-19, public health, and personal liberties have reached a fever pitch, tugging at tightknit towns and making some residents wonder how their communities will survive.
One California University Has Unified Town and Gown to Fight Covid. Why Haven’t Others?
The University of California-Davis has spent close to $50 million preventing the spread of covid on campus — and among residents and workers in the adjacent city of Davis. By most accounts, this town-gown experiment has paid off nicely.
The CDC’s New Guidelines on Covid Risk and Masking Send Confounding Signals
The agency’s updated recommendations lower the level of covid risk for most of the country and therefore the need to mask. But some experts question the strategy.
The NFL Has Been Using an Unproven Measure to Get Players With Covid Back on the Field Fast
Doctors and scientists are debating whether a little-known measure in covid testing should be used to distinguish who is infectious from who isn’t. The NFL adopted the practice, but laboratory professionals caution against its use.
Charts Paint a Grim Picture 2 Years Into the Coronavirus Pandemic
The on-off nature of the pandemic “has led to a lot of the confusion and grumpiness,” says one expert. Another compares it to the exhaustion of the American public when hearing body counts during the Vietnam War.
Watch: California’s Top Health Adviser on Learning to Live With Covid
KHN Senior Correspondent Samantha Young joined California Health and Human Services Secretary Mark Ghaly for an engaging conversation about how California moves forward in an environment in which covid persists, but at more manageable levels.
Poco más del 57% de los adolescentes de 12 a 17 años y el 62% de los jóvenes de 18 a 24 años están completamente vacunados. Para estas franjas de edad covid también puede ser mortal.
When Teens Blow Off Parents’ Pleas to Get Vaccinated, the Consequences Can Be Deadly
Kennedy Stonum, a 17-year-old high school junior, resisted getting vaccinated against covid-19, as did 20-year-old Tyler Gilreath, whose mother had nagged him for months to get the shots. Both died.
KHN’s ‘What the Health?’: A Health-Heavy State of the Union
President Joe Biden spent a large portion of his first State of the Union address talking about foreign affairs, but he also spent time on an array of health topics, including mental health, nursing home regulation, and toxic burn pits. Also this week, the administration unveiled a strategy to address the covid pandemic going forward. Alice Miranda Ollstein of Politico, Amy Goldstein of The Washington Post, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
To Be One in a Million: ‘Who Thinks It’s Going to Be You?’
Stan Thomas’ wife, Monica Melkonian, was one of only nine people in the U.S. confirmed to have died from vaccine-induced immune thrombotic thrombocytopenia, a rare side effect associated with the Johnson & Johnson covid vaccine. For the first time, Thomas shares her story of how excited she was to get the shot, how she died, and why he remains firmly pro-vaccine.
Covid Expert Joins Exodus Into Business, Where Science Parlays Into Profits
Like others in academia or government who’ve served as public health advisers during the pandemic, Dr. Michael Mina traded his university role for a commercial venture. He recently took a top job at eMed, a startup that charges a premium price for monitoring at-home covid tests. Can experts do well by trying to do good?
Vacunados con J&J, reforzados con ARNm, y pensando en la tercera dosis
Cerca de 17 millones de personas que recibieron la vacuna de Johnson & Johnson contra covid se preguntan cuántas dosis necesitan.
J&J-Vaxxed, mRNA-Boosted, and Pondering a Third Shot
Many of the nearly 17 million U.S. members of J&J Nation, myself included, are wondering whether to set aside the current official guidance and get a second booster. Some experts say: Chill out.
